Algo version: 0.98b
INTS is listed at the NASDAQ Exchange
INTS [INTS]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is INTS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Intensity Therapeutics, 10 years ago, but if you had invested on Thursday 13th of October 2022 when the price was $0.0000, you would have made a profit of $3.21 per share or 32 099 900.00%

No, the average daily trading liquidity for Intensity Therapeutics, is $53 437 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Intensity Therapeutics, has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Intensity Therapeutics, to be medium [0.7 out of 1]